Literature DB >> 8977235

Multiple signaling pathways induced by granulocyte colony-stimulating factor involving activation of JAKs, STAT5, and/or STAT3 are required for regulation of three distinct classes of immediate early genes.

S S Tian1, P Tapley, C Sincich, R B Stein, J Rosen, P Lamb.   

Abstract

Granulocyte colony-stimulating factor (G-CSF) is the major regulator of proliferation and differentiation of neutrophilic granulocyte precursor cells. G-CSF activates multiple signaling molecules, including the JAK1 and JAK2 kinases and the STAT transcription factors. To investigate G-CSF signaling events regulated by the JAK-STAT pathway, we have generated UT7-epo cells stably expressing either wild-type (wt) G-CSF receptor or a series of C-terminal deletion mutants. Gel mobility shift and immunoprecipitation/Western analysis showed that STAT5 is rapidly activated by G-CSF in cells expressing the wt G-CSF receptor, in addition to the previously reported STAT3 and STAT1. Mutants lacking any tyrosine residues in the cytoplasmic domain maintain their ability to activate STAT5 and STAT1 but cannot activate STAT3, implying that STAT5 and STAT1 activation does not require receptor tyrosine phosphorylation. We also observed significant changes in the ratio of STAT1:STAT3:STAT5 activated by various G-CSF receptor C-terminal deletion mutants. These mutant receptors were further used to investigate the role of JAKs and STATs in G-CSF-mediated responses in these cells. We found that JAK activation correlates with G-CSF-induced cell proliferation, whereas STAT activation is not required. We have also identified three classes of G-CSF immediate early genes, whose activation correlates with the activation of distinct JAK-STAT pathways. Our data show that, whereas c-fos is regulated through a pathway independent of STAT activation, oncostatin M, IRF-1, and egr-1 are regulated by an STAT5-dependent pathway and fibrinogen is regulated by an STAT3-dependent pathway. In conclusion, our results suggest that G-CSF regulates its complex biologic activities by selectively activating distinct early response genes through different JAK-STAT signaling molecules.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8977235

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  40 in total

1.  Chromatin acetylation and remodeling at the Cis promoter during STAT5-induced transcription.

Authors:  Anne Rascle; Emma Lees
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

Review 2.  Src family kinases and the MEK/ERK pathway in the regulation of myeloid differentiation and myeloid leukemogenesis.

Authors:  Daniel E Johnson
Journal:  Adv Enzyme Regul       Date:  2007-11-19

3.  miR-590-5p, miR-219-5p, miR-15b and miR-628-5p are commonly regulated by IL-3, GM-CSF and G-CSF in acute myeloid leukemia.

Authors:  Amanda J Favreau; Pradeep Sathyanarayana
Journal:  Leuk Res       Date:  2011-10-19       Impact factor: 3.156

4.  Distinct signaling programs control human hematopoietic stem cell survival and proliferation.

Authors:  David J H F Knapp; Colin A Hammond; Nima Aghaeepour; Paul H Miller; Davide Pellacani; Philip A Beer; Karen Sachs; Wenlian Qiao; WeiJia Wang; R Keith Humphries; Guy Sauvageau; Peter W Zandstra; Sean C Bendall; Garry P Nolan; Carl Hansen; Connie J Eaves
Journal:  Blood       Date:  2016-11-08       Impact factor: 22.113

5.  Autocrine signaling based selection of combinatorial antibodies that transdifferentiate human stem cells.

Authors:  Jia Xie; Hongkai Zhang; Kyungmoo Yea; Richard A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-23       Impact factor: 11.205

Review 6.  Systems approach to phagocyte production and activation: neutrophils and monocytes.

Authors:  Hrishikesh M Mehta; Taly Glaubach; Seth Joel Corey
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

7.  Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor.

Authors:  David C Dale; Audrey Anna Bolyard; Tracy Marrero; Merideth L Kelley; Vahagn Makaryan; Emily Tran; Jamie Leung; Laurence A Boxer; Priya S Kishnani; Stephanie Austin; Corbinian Wanner; Iris A Ferrecchia; Dina Khalaf; Dawn Maze; Joanne Kurtzberg; Cornelia Zeidler; Karl Welte; David A Weinstein
Journal:  Curr Opin Hematol       Date:  2019-01       Impact factor: 3.284

Review 8.  STAT3 regulation of glioblastoma pathogenesis.

Authors:  Núria de la Iglesia; Sidharth V Puram; Azad Bonni
Journal:  Curr Mol Med       Date:  2009-06       Impact factor: 2.222

9.  Revascularization and muscle adaptation to limb demand ischemia in diet-induced obese mice.

Authors:  Hassan Albadawi; A Aria Tzika; Christian Rask-Madsen; Lindsey M Crowley; Michael W Koulopoulos; Hyung-Jin Yoo; Michael T Watkins
Journal:  J Surg Res       Date:  2016-06-08       Impact factor: 2.192

10.  The haematopoietic GTPase RhoH modulates IL3 signalling through regulation of STAT activity and IL3 receptor expression.

Authors:  Mehtap S Gündogdu; He Liu; Daniela Metzdorf; Dagmar Hildebrand; Michael Aigner; Klaus Aktories; Klaus Heeg; Katharina F Kubatzky
Journal:  Mol Cancer       Date:  2010-08-25       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.